ETHEX Corporation voluntarily recalled specific additional lots of morphine sulfate 60 mg extended release tablets, and specific lots of morphine sulfate 30 mg extended release tablets, due to the possible presence of oversized tablets. Oversized tablets may contain as much as two times the labeled level of active morphine sulfate. The recalled lots were distributed by ETHEX Corporation under an "ETHEX" label between June 2006 and May 2008. The lot numbers involved in the recall are: Morphine Sulfate ER 30mg Tablet/NDC # 58177-320-04: Lots 75090, 77846, 77847, 80048, 83320, 89661, 89665, 90252 through 90258, and 93284- Morphine Sulfate ER 60mg Tablet/NDC # 58177-330-04: Lots 91762 (previously reported), 75091, 75092, 77848 through 77851, 82517, 82518, 83333, 83817, 83862, 84111, 84112, 84315, 84900, 85326, 85335, 85807, 86270 through 86276, 87723, 87939, 88007, 89083, 89668, 89669, 89821, 90260 through 90272, and 91763 through 91765. Opioids such as morphine, have life-threatening consequences if overdosed. Those consequences can include respiratory depression (difficult y or lack of breathing), and low blood pressure, apnea, and hypotension. The voluntary recall follows a report that a tablet with as much as double the appropriate thickness was identified in a previously recalled lot. The 60 mg product is a white oval tablet with "60" on one side, and "E" on the reverse. The 30 mg product is a pink oval tablet with "30" on one side, and "E" on the reverse.